GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Other Income (Expense)

Godavari Drugs (BOM:530317) Other Income (Expense) : ₹-12 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Other Income (Expense)?

Godavari Drugs's other income expense for the Godavari Drugs's pretax income for the three months ended in Dec. 2023 was ₹-0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-12 Mil.

Godavari Drugs Other Income (Expense) Historical Data

The historical data trend for Godavari Drugs's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Other Income (Expense) Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 2.11 3.30 -0.79 -11.81

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 -16.78 4.52 0.04 -0.08

Godavari Drugs Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Godavari Drugs  (BOM:530317) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Godavari Drugs (BOM:530317) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Other Income (Expense)
Comparable Companies
BOM:506919 BOM:524711 BOM:542248 BOM:530233 BOM:524703 BOM:524202 BOM:524396 BOM:537253 BOM:542678 NSE:JFLLIFE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Website
https://www.godavaridrugs.com
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines